bioAffinity Technologies (BIAFW) Total Liabilities (2021 - 2026)

bioAffinity Technologies (BIAFW) has 6 years of Total Liabilities data on file, last reported at $4.3 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $4.3 million, up 4.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 4.28% YoY), and the FY2025 annual result was $3.7 million, down 5.84% from the prior year.
• Total Liabilities improved to $4.3 million in Q1 2026 per BIAFW's latest filing, from $3.7 million in the prior quarter.
• Over five years, Total Liabilities peaked at $16.8 million in Q2 2022 and troughed at $775151.0 in Q2 2023.
• A 5-year average of $4.7 million and a median of $3.4 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities plunged 95.38% in 2023, then jumped 315.83% in 2024.
• A 5-year view of Total Liabilities shows it stood at $1.1 million in 2022, then surged by 195.63% to $3.4 million in 2023, then gained by 16.2% to $3.9 million in 2024, then fell by 5.84% to $3.7 million in 2025, then grew by 16.31% to $4.3 million in 2026.
• Business Quant data shows BIAFW's Total Liabilities at $4.3 million in Q1 2026, $3.7 million in Q4 2025, and $2.6 million in Q3 2025.